121 related articles for article (PubMed ID: 37431249)
21. Survival outcomes and patterns of failure in women with stage IIIC
Lee JK; Mahan M; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
[TBL] [Abstract][Full Text] [Related]
22. Clinical statistics of gynecologic cancers in Japan.
Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Aoki D; Katabuchi H
J Gynecol Oncol; 2017 Mar; 28(2):e32. PubMed ID: 28198168
[TBL] [Abstract][Full Text] [Related]
23. What Is the Optimal Adjuvant Treatment Sequence for Node-Positive Endometrial Cancer? Results of a National Cancer Database Analysis.
Modh A; Ghanem AI; Burmeister C; Hanna RK; Elshaikh MA
Int J Gynecol Cancer; 2018 Feb; 28(2):248-253. PubMed ID: 29240603
[TBL] [Abstract][Full Text] [Related]
24. A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer.
Feldman A; Chaugle S; Burmeister C; Munkarah A; Elshaikh MA
Gynecol Obstet Invest; 2019; 84(3):283-289. PubMed ID: 30540995
[TBL] [Abstract][Full Text] [Related]
25. Thyroid Cancer Incidence in Bulgaria before and after the Introduction of Universal Salt Iodization: An Analysis of the National Cancer Registry Data.
Ivanova LB; Vukov MI; Vassileva-Valerianova ZG
Balkan Med J; 2020 Oct; 37(6):330-335. PubMed ID: 32856882
[TBL] [Abstract][Full Text] [Related]
26. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
Dimitrova N; Parkin DM
Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
[TBL] [Abstract][Full Text] [Related]
27. Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis.
Isrow D; Burmeister C; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():115-120. PubMed ID: 27838535
[TBL] [Abstract][Full Text] [Related]
28. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
Boll D; Verhoeven RH; van der Aa MA; Pauwels P; Karim-Kos HE; Coebergh JW; van Doorn HC
Int J Gynecol Cancer; 2012 May; 22(4):599-606. PubMed ID: 22398706
[TBL] [Abstract][Full Text] [Related]
29. Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis.
Onal C; Yuce Sari S; Akkus Yildirim B; Gultekin M; Guler OC; Yildiz F
J Obstet Gynaecol; 2020 Oct; 40(7):1012-1019. PubMed ID: 31793400
[TBL] [Abstract][Full Text] [Related]
30. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
[TBL] [Abstract][Full Text] [Related]
31. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
32. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
33. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.
Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP
PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921
[TBL] [Abstract][Full Text] [Related]
34. Cancer of the Cervix in Bulgaria: Epidemiology of a Crisis.
Yordanov A; Vasileva-Slaveva M; Galai N; Faraggi D; Kubelac MP; Tripac-Iacovleva I; Calleja N; Di Fiore R; Calleja-Agius J
Healthcare (Basel); 2023 Jan; 11(3):. PubMed ID: 36766893
[TBL] [Abstract][Full Text] [Related]
35. Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.
Ayhan A; Topfedaisi Ozkan N; Öz M; Kimyon Comert G; Firat Cuylan Z; Çoban G; Turkmen O; Erdem B; Şahin H; Akbayır Ö; Dede M; Turan AT; Celik H; Güngör T; Haberal A; Arvas M; Meydanli MM
J Gynecol Oncol; 2018 Jul; 29(4):e48. PubMed ID: 29770619
[TBL] [Abstract][Full Text] [Related]
36. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
[TBL] [Abstract][Full Text] [Related]
37. Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry.
Scharl S; Papathemelis T; Kronberger K; Gerken M; Scharl A; Kölbl O; Klinkhammer-Schalke M
Arch Gynecol Obstet; 2018 May; 297(5):1245-1253. PubMed ID: 29417286
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
[TBL] [Abstract][Full Text] [Related]
39. Endometrial carcinoma in Portugal: demographic, diagnostic and treatment changes in the last 5 decades.
Bartosch C; Gomes B; Jerónimo C; Lopes JM
Int J Gynecol Pathol; 2015 Mar; 34(2):159-68. PubMed ID: 25675186
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
